URACYL-SPIROOXETAN-NUKLEOSIDE

Patent europeic · EP2861611 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2861611
Numer da la dumonda
EP13727080
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
24-05-2013
Publitgà
22-04-2015
Concedì
13-07-2016
Stritgà
23-12-2025
Motiv
Taxa annuala betg pajada
Classas IPC
C07H 19/11 (2006.01)
A61K 31/7072 (2006.01)
A61P 31/14 (2006.01)
Prioritad
EP 12169425 25.05.2012
Dumonda PCT
PCT/EP2013/060704 24.05.2013
Publicaziun PCT
WO2013/174962 28.11.2013
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 23-12-2025

    Stritgà, taxa betg pajada

    Status of protective title
    Active → Cancelled
    Cancellation date
    23.12.2025
    Cause for cancellation
    Non-payment of renewal fee

    Published in Swissreg on 23.12.2025

  2. 02-06-2024

    Midada

    Published in Swissreg on 02.06.2024

  3. 01-06-2023

    Midada

    Published in Swissreg on 01.06.2023

  4. 13-07-2016

    Concedì

    Published in Swissreg on 13.07.2016

Partidas

Possessur

Janssen Sciences Ireland UC

Eastgate Village, Eastgate, Little Island, County Cork, IE

Inventur

HOUPIS, Ioannis Nicolaos

B-2018 Antwerp, BE

JONCKERS, Tim Hugo Maria

B-2220 Heist-op-den-Berg, BE

RABOISSON, Pierre Jean-Marie Bernard

B-1331 Rosieres, BE

TAHRI, Abdellah

B-1070 Anderlecht, BE

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.